Tumor marker tracker: a chart for your doctor
Enter your CEA, CA-125, CA 19-9, PSA and other marker results to see the trend on a chart and the percentage change. Data stays only in your browser; print or download the table.
Data is stored only in this browser and isn't sent anywhere. Clearing the browser deletes it, so download the table now and then.
Trend
Add at least two results for one marker — a chart and the percentage change between the latest tests will appear here.
Compare results from the same lab: methods and reference ranges differ. A single rise is a reason to show the chart to your doctor, not proof of progression: decisions are based on scans and symptoms.
How to look at tumor markers
According to the US National Cancer Institute, tumor markers are most useful over time: they help show whether treatment is working and spot a recurrence. One number means little — what matters is the line across several tests.
Markers rise for reasons other than cancer too: inflammation, liver disease, smoking and other conditions. A temporary rise can also happen at the start of effective treatment. So decisions are based on scans and how you feel, and the marker chart is a reason to talk to your doctor.
Common questions
Where is my data stored?
Only in your browser on this device. We don't see or receive it. To avoid losing your entries, download the table from time to time.
My marker went up 20% — is it progression?
Not necessarily. Small swings happen because of the lab and other factors. A steady rise over several tests in a row matters, and even then decisions are made on CT or PET-CT.
Sources
- Tumor Markers — National Cancer Institute
- Tumor Markers in Common Use — National Cancer Institute
Other tools
- When to call your doctorFever, diarrhea, breathlessness during treatment: urgent or can it wait
- Blood count before chemoAre your neutrophils and platelets enough for the next cycle
- Chemotherapy calendarDates of cycles, blood tests and higher-risk days — export to your phone calendar
- TNM decoderWhat T, N and M mean in your report
- Breast cancer IHC decoderYour tumor subtype from ER, PR, HER2 and Ki-67
- Second opinion checklistWhat to gather before a consultation: a list for your case
